COMPARISON OF TOOLS USED TO IMPROVE COMMUNICATION WITH FOREIGN PATIENTS IN SANITARY CENTERS IN THE UNITED KINGDOM, GERMANY AND SPAIN

被引：0
|
作者：
Faya Ornia, Goretti [1 ]
机构：
[1] Univ Oviedo, Oviedo, Spain
来源：
SENDEBAR-REVISTA DE TRADUCCION E INTERPRETACION | 2011年 / 22期
关键词：
Communicative problems at health centres; comparison between UK; Germany and Spain; interpretation in health environments; technological interpretation tools at health centres;
D O I：
暂无
中图分类号：
H [语言、文字];
学科分类号：
05 ;
摘要：
The present study has two objectives: firstly, to explain and compare the measures regarding translation and interpretation which are adopted in different health centres in the United Kingdom, Germany and Spain; and secondly, to detail some of the most solicited and frequently used technological tools which are designed to solve communicative problems arising in these centres. After a brief review of the state of the art, I will present: (a) data obtained through a questionnaire sent to various health centres, and (b) information extracted from a study of different technological tools which facilitate multilingual communication in health centres. In the conclusions, I will focus on some ethical issues which may be studied in the future.
引用
收藏
页码：191 / 208
页数：18
相关论文
共 42 条
  • [31] Real-world treatment patterns in patients initiating third-line therapy for relapsed or refractory multiple myeloma in Germany, Italy, the United Kingdom, France, and Spain
    Lehne, Moritz
    Kortum, K. Martin
    Ramasamy, Karthik
    Zamagni, Elena
    d'Estrube, Tim
    Zhuleku, Evi
    Hanna, Maya
    Shukla, Soham
    Ghiani, Marco
    Maywald, Ulf
    Wilke, Thomas
    Kellermann, Lenka
    Perera, Sue
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2024, 112 (05) : 701 - 713
  • [32] SKELETAL-RELATED EVENTS (SRES) AND RENAL FUNCTION IN PATIENTS WITH SYMPTOMATIC MULTIPLE MYELOMA (MM): RESULTS FROM BELGIUM, FRANCE, GERMANY, ITALY, SPAIN, SWITZERLAND AND THE UNITED KINGDOM
    Gonzalez-McQuire, S.
    Intorcia, M.
    Gatta, F.
    Schoen, P.
    Fink, L.
    Gazzola, C.
    Flinois, A.
    Yong, K.
    Raab, M.
    Leleu, H.
    VALUE IN HEALTH, 2016, 19 (07) : A760 - A760
  • [33] Impact of disease location on burden of illness in patients with moderate-severe Crohn's disease: A real-world survey in the United States, France, Germany, Italy, Spain, and United Kingdom (5EU)
    Sikirica, M.
    Lynch, J.
    Kershaw, J.
    Lukanova, R.
    Baker, S.
    Milligan, G.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I230 - I230
  • [34] Headache-Free Days among Migraine Patients and its Association with Burden: A Cross-Sectional Analysis of 2017 Survey Data in France, Germany, Italy, Spain, and the United Kingdom
    Doane, Michael J.
    Gupta, Shaloo
    Fang, Juanzhi
    Laflamme, Annik
    Ranjan, Pallavi
    Vo, Pamela
    CEPHALALGIA, 2019, 39 : 132 - 133
  • [35] Persistent burden of disease in patients with Crohn's disease treated with biologic therapy: results from a real-world survey in the United States (US), France, Germany, Italy, Spain, and United Kingdom (5EU)
    Sikirica, M.
    Lynch, J.
    Kershaw, J.
    Lukanova, R.
    Baker, S.
    Milligan, G.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I292 - I293
  • [36] Use of perioperative treatment (tx) among patients (pts) undergoing radical resection (RR) for muscle-invasive urothelial cancer (MIUC) in France, Germany, Italy, Spain, the United Kingdom, the United States, Canada, China, and Japan.
    Broughton, Edward I.
    Gschwend, Juergen E.
    Witjes, J. Alfred
    Berry, Mia
    Kostikas, Michael
    Montgomery, Rachel
    Lambert, Annabel
    Teitsson, Siguroli
    Milloy, Neil
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [37] Economic Burden of Migraine Patients with Eight or More Headache Days per Month: A Cross-Sectional Analysis of Survey Data in the EU5 (France, Germany, Italy, Spain, and the United Kingdom)
    Doane, Michael J.
    Gupta, Shaloo
    Fang, Juanzhi
    Laflamme, Annik
    Ranjan, Pallavi
    Vo, Pamela
    CEPHALALGIA, 2019, 39 : 121 - 122
  • [38] Treatment pattern by hormone receptors and HER2 status in patients with metastatic breast cancer in the United Kingdom, Germany, France, Spain, and Italy (EU-5): Results from a physician survey
    DeKoven, Mitch
    Bonthapally, Vijayveer
    Lee, Won Chan
    Pathak, Prathamesh
    Jiao, Xiaolong
    Ray, Saurabh
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [39] Cost-effectiveness of zoledronic acid in the prevention of skeletal-related events in patients with bone metastases from renal cell carcinoma: Comparison between France, Germany, and the United Kingdom
    Botteman, M. F.
    Kaura, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [40] Criteria used to determine platinum eligibility and first-line (1L) treatment (tx) patterns among platinum-eligible (PE) and -ineligible (PI) patients (pts) with metastatic urothelial cancer (mUC) in France, Germany, Spain, Italy, and the United Kingdom (Eu5).
    Milloy, Neil
    Kirker, Melissa
    Berry, Mia
    Kostikas, Michael
    Montgomery, Rachel
    Kearney, Mairead
    Costa, Nuno Matos
    Chang, Jane
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
12345